Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action.

Author: CandelettiSanzio, CaputiFrancesca F, NicoraMariaflavia, RomualdiPatrizia, SimeoneRoberto

Paper Details 
Original Abstract of the Article :
Chronic pain treatment represents one of the most complex clinical challenges and even though opioids exhibit particular efficacy on nociceptive pain, their use must be controlled to avoid the risk of adverse reactions. A useful approach, aimed at maintaining analgesia and mitigating side effects, i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.23736/S0026-4806.18.05909-8

データ提供:米国国立医学図書館(NLM)

Tapentadol: A Unique Analgesic with Dual Mechanisms of Action

This review examines the analgesic properties of tapentadol, a novel medication that offers a distinct approach to pain management. The authors recognize the challenges associated with chronic pain management, particularly the risks associated with opioid use. The review delves into the unique mechanism of action of tapentadol, which combines µ-opioid receptor agonism and noradrenaline reuptake inhibition. The authors explore tapentadol's efficacy and tolerability profile, seeking to provide a comprehensive overview of its potential as a safe and effective analgesic.

Tapentadol's Unique Analgesic Profile

The review highlights tapentadol's unique analgesic profile, emphasizing its dual mechanisms of action. The combination of µ-opioid receptor agonism and noradrenaline reuptake inhibition allows tapentadol to provide effective pain relief while potentially minimizing the risks associated with traditional opioids. The review also underscores tapentadol's favorable tolerability profile, particularly its good gastrointestinal tolerability and minimal impact on hormone levels and cognitive performance.

A Promising Option for Chronic Pain Management

This review presents tapentadol as a promising option for managing chronic pain. The authors emphasize its unique analgesic profile, combining effective pain relief with a favorable tolerability profile. The review encourages further research to explore tapentadol's potential in various pain conditions and to further define its long-term safety and efficacy.

Dr.Camel's Conclusion

This review introduces us to tapentadol, a novel analgesic that offers a unique approach to pain management. The authors' comprehensive analysis highlights tapentadol's potential benefits, including its dual mechanisms of action and favorable tolerability profile. The review encourages further exploration of tapentadol's role in managing chronic pain, potentially offering a safer and more effective alternative to traditional opioid-based therapies.

Date :
  1. Date Completed 2019-02-07
  2. Date Revised 2019-02-15
Further Info :

Pubmed ID

30667206

DOI: Digital Object Identifier

10.23736/S0026-4806.18.05909-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.